Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125468451 | 12546845 | 1 | I | 20160706 | 20160711 | 20160711 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201607001668 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160708 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125468451 | 12546845 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Unknown | UNK, UNKNOWN | Y | U | 20592 | TABLET | |||||||
125468451 | 12546845 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 1050 MG, SINGLE | Y | U | 20592 | 1050 | MG | TABLET | |||||
125468451 | 12546845 | 3 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 1350 MG, SINGLE | Y | U | 20592 | 1350 | MG | TABLET | |||||
125468451 | 12546845 | 4 | SS | ZOPICLONE | ZOPICLONE | 1 | Unknown | UNK, UNKNOWN | Y | U | 0 | ||||||||
125468451 | 12546845 | 5 | SS | ZOPICLONE | ZOPICLONE | 1 | Oral | 210 MG, SINGLE | Y | U | 0 | 210 | MG | ||||||
125468451 | 12546845 | 6 | SS | LYSANXIA | PRAZEPAM | 1 | Unknown | UNK, UNKNOWN | Y | U | 0 | TABLET | |||||||
125468451 | 12546845 | 7 | SS | LYSANXIA | PRAZEPAM | 1 | Oral | 1440 MG, SINGLE | Y | U | 0 | 1440 | MG | TABLET | |||||
125468451 | 12546845 | 8 | SS | SEROPLEX | ESCITALOPRAM OXALATE | 1 | Unknown | UNK, UNKNOWN | Y | U | 0 | ||||||||
125468451 | 12546845 | 9 | SS | SEROPLEX | ESCITALOPRAM OXALATE | 1 | Oral | 140 MG, SINGLE | Y | U | 0 | 140 | MG | ||||||
125468451 | 12546845 | 10 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | UNK, UNKNOWN | Y | U | 0 | ||||||||
125468451 | 12546845 | 11 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, UNKNOWN | Y | U | 0 | 10 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125468451 | 12546845 | 1 | Product used for unknown indication |
125468451 | 12546845 | 4 | Product used for unknown indication |
125468451 | 12546845 | 6 | Product used for unknown indication |
125468451 | 12546845 | 8 | Product used for unknown indication |
125468451 | 12546845 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125468451 | 12546845 | OT |
125468451 | 12546845 | LT |
125468451 | 12546845 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125468451 | 12546845 | Agitation | |
125468451 | 12546845 | Antipsychotic drug level above therapeutic | |
125468451 | 12546845 | Benzodiazepine drug level | |
125468451 | 12546845 | Body temperature decreased | |
125468451 | 12546845 | Coma | |
125468451 | 12546845 | Confusional state | |
125468451 | 12546845 | Electrocardiogram QT prolonged | |
125468451 | 12546845 | Hypotension | |
125468451 | 12546845 | Hypotonia | |
125468451 | 12546845 | Intentional overdose | |
125468451 | 12546845 | Loss of consciousness | |
125468451 | 12546845 | Miosis | |
125468451 | 12546845 | Pneumonia aspiration | |
125468451 | 12546845 | Respiratory rate increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125468451 | 12546845 | 2 | 20160511 | 20160511 | 0 | |
125468451 | 12546845 | 3 | 20160511 | 20160511 | 0 | |
125468451 | 12546845 | 5 | 20160511 | 20160511 | 0 | |
125468451 | 12546845 | 7 | 20160511 | 20160511 | 0 | |
125468451 | 12546845 | 9 | 20160511 | 20160511 | 0 | |
125468451 | 12546845 | 11 | 20160511 | 20160511 | 0 |